Barbara Adamik

1.9k total citations
60 papers, 803 citations indexed

About

Barbara Adamik is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara Adamik has authored 60 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Immunology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara Adamik's work include Sepsis Diagnosis and Treatment (20 papers), COVID-19 Clinical Research Studies (9 papers) and Immune Response and Inflammation (9 papers). Barbara Adamik is often cited by papers focused on Sepsis Diagnosis and Treatment (20 papers), COVID-19 Clinical Research Studies (9 papers) and Immune Response and Inflammation (9 papers). Barbara Adamik collaborates with scholars based in Poland, United States and Sweden. Barbara Adamik's co-authors include Andrzej Kübler, Waldemar Goździk, Farshid N. Rouhani, Stewart J. Levine, Aminul Islam, Jing Zhang, Andrzej Gamian, Feras Hawari, Michał Zimecki and Joanna Kübler-Kiełb and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Barbara Adamik

58 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Adamik Poland 18 243 198 174 129 122 60 803
Bangchuan Hu China 16 139 0.6× 179 0.9× 71 0.4× 86 0.7× 75 0.6× 50 718
Ignace Demeyer Belgium 12 273 1.1× 142 0.7× 262 1.5× 212 1.6× 208 1.7× 16 979
Michael J. O’Dwyer United Kingdom 19 343 1.4× 97 0.5× 174 1.0× 228 1.8× 199 1.6× 40 1.0k
Gordon P Otto Germany 12 362 1.5× 200 1.0× 365 2.1× 95 0.7× 165 1.4× 20 934
Yoshihisa Tateishi Japan 18 376 1.5× 200 1.0× 238 1.4× 155 1.2× 121 1.0× 40 1.2k
John Constant United States 5 469 1.9× 191 1.0× 353 2.0× 101 0.8× 156 1.3× 10 951
Joanna Warszawska Austria 15 233 1.0× 155 0.8× 350 2.0× 206 1.6× 70 0.6× 18 1.1k
Zhenghui Xiao China 14 153 0.6× 210 1.1× 121 0.7× 87 0.7× 44 0.4× 86 690
Anqiang Zhang China 19 303 1.2× 187 0.9× 218 1.3× 100 0.8× 55 0.5× 50 753
Konstantinos Thomopoulos Greece 20 564 2.3× 201 1.0× 121 0.7× 296 2.3× 42 0.3× 66 1.3k

Countries citing papers authored by Barbara Adamik

Since Specialization
Citations

This map shows the geographic impact of Barbara Adamik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Adamik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Adamik more than expected).

Fields of papers citing papers by Barbara Adamik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Adamik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Adamik. The network helps show where Barbara Adamik may publish in the future.

Co-authorship network of co-authors of Barbara Adamik

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Adamik. A scholar is included among the top collaborators of Barbara Adamik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Adamik. Barbara Adamik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goździk, Waldemar, et al.. (2025). Hemolysis and Its Clinical Implications in Septic Patients with Acute Respiratory Failure. Journal of Clinical Medicine. 14(10). 3493–3493.
2.
Sokolski, Mateusz, Barbara Adamik, Katarzyna Kiliś‐Pstrusińska, et al.. (2024). Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study. Scientific Reports. 14(1). 4832–4832. 2 indexed citations
4.
Matera-Witkiewicz, Agnieszka, Adrian Doroszko, Małgorzata Trocha, et al.. (2023). Usefulness of the Veterans Health Administration COVID-19 (VACO) Index for Predicting Short-Term Mortality among Patients of the COLOS Study. Journal of Clinical Medicine. 12(19). 6262–6262. 1 indexed citations
6.
Letachowicz, Krzysztof, Barbara Adamik, Adrian Doroszko, et al.. (2023). Dysnatremia in COVID-19 Patients—An Analysis of the COLOS Study. Journal of Clinical Medicine. 12(8). 2802–2802. 2 indexed citations
7.
Adamik, Barbara, et al.. (2022). Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients. Shock. 57(5). 672–679. 6 indexed citations
9.
Biecek, Przemysław, et al.. (2022). Explainable Artificial Intelligence Helps in Understanding the Effect of Fibronectin on Survival of Sepsis. Cells. 11(15). 2433–2433. 9 indexed citations
10.
Adamik, Barbara, et al.. (2022). Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients. Cells. 11(9). 1566–1566. 5 indexed citations
11.
Lipińska-Gediga, Małgorzata, et al.. (2022). Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens. 11(12). 1526–1526. 12 indexed citations
12.
Kaliszewski, Krzysztof, Dorota Diakowska, Łukasz Nowak, et al.. (2022). Assessment of Gastrointestinal Symptoms and Dyspnea in Patients Hospitalized due to COVID-19: Contribution to Clinical Course and Mortality. Journal of Clinical Medicine. 11(7). 1821–1821. 5 indexed citations
13.
Kalicińska, Elżbieta, Barbara Adamik, Danuta Nowicka‐Suszko, et al.. (2021). Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study. Cells. 10(6). 1293–1293. 20 indexed citations
14.
Adamik, Barbara, Claes Frostell, Urszula Pasławska, et al.. (2021). Platelet dysfunction in a large-animal model of endotoxic shock; effects of inhaled nitric oxide and low-dose steroid. Nitric Oxide. 108. 20–27. 3 indexed citations
15.
Adamik, Barbara, et al.. (2021). Platelet Receptor Activity for Predicting Survival in Patients with Intracranial Bleeding. Journal of Clinical Medicine. 10(10). 2205–2205. 2 indexed citations
16.
Goździk, Waldemar, et al.. (2020). Brain-Specific Biomarkers as Mortality Predictors after Aneurysmal Subarachnoid Haemorrhage. Journal of Clinical Medicine. 9(12). 4117–4117. 7 indexed citations
17.
Adamik, Barbara, et al.. (2020). Plasma and Cellular Forms of Fibronectin as Prognostic Markers in Sepsis. Mediators of Inflammation. 2020. 1–9. 5 indexed citations
18.
Adamik, Barbara, et al.. (2020). Elevated Procalcitonin as a Risk Factor for Postoperative Delirium in the Elderly after Cardiac Surgery—A Prospective Observational Study. Journal of Clinical Medicine. 9(12). 3837–3837. 6 indexed citations
19.
Goździk, Waldemar, et al.. (2020). Biomarkers of Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit. Neurocritical Care. 34(3). 856–866. 18 indexed citations
20.
Adamik, Barbara, et al.. (2019). Fibronectin and its soluble EDA-FN isoform as biomarkers for inflammation and sepsis. Advances in Clinical and Experimental Medicine. 28(11). 1561–1567. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026